Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
406 Intravenously injected cRGD-siRNA molecules produced no innate immune response in mice with transplanted tumors
Papaseit E et al
Worked good
Pulsatile exposure matters more than cumulative dose
The advantage of the combination is biological coverage that no single peptide provides alone, but it also asks for more clinical oversight
These treatments are usually not covered by insurance and are pretty pricey about $150$200 per treatment so clients are likely to want the therapy to work since they just paid a lot of money for it
US$ 29.36
US$ 24.65
US$ 29.87
